Our Points of Distinction
Cutting-Edge Technology and IP Platform
Predictive Design: creating an editing blueprint through deep learning and machine learning
Advanced Multiplex Gene Editing Toolkit: facilitating multiple edits across multiple genes
A rich pool of intellectual property with broad application
Well-Defined Commercial Strategy
Unique commercial relationships with Independent Seed Companies (ISCs) selling directly to farmers
A superior feedback loop between Inari and farmers via ISCs, informing future products
Strategic partnerships with leading seed companies enabling market expansion in new crops and regions
Step-Change
Products
Sustainability Impact: focusing on the world's largest crop types
Efficiency Improvements: product pipeline includes fertilizer and water use
Yield Increase: projecting as much as +20% in Inari's current crops vs. historical increases of ~1% per year
Diverse and Highly Experienced Team
Unparalleled experience across agriculture, biotech, commercial, intellectual property and academia
Active support from a world-class Scientific Strategy Board composed of genetics experts from top global institutions - including Jennifer Doudna, 2020 winner of the Nobel Prize in Chemistry for the development of CRISPR-Cas9
Who We Are
Ambitiously Grounded
We embrace challenges and are willing to take risks to deliver high impact results. We respect diverse views - seeking out and supporting ideas from others.
Collaborative Innovators
We are curious explorers who believe collaboration can overcome limitations and expedite success. We bring new people together to cultivate diversity in thinking, development and execution.
Stewards of Our Planet
We hold ourselves accountable for the footprint that we create and strive to protect the Earth for future generations.
Our Leadership Team
Inari's leadership brings a wealth of knowledge and experience to drive the business forward through collaboration with team members at every level. They are both accessible and deeply involved - inspiring, innovating and mentoring to ensure the success of the organization well into the future.

Ponsi Trivisvavet
CEO AND DIRECTOR
READ BIO
About Ponsi Trivisvavet
Ponsi’s broad management expertise in global agriculture has helped her build Inari into the cutting-edge SEEDesign™ technology company. Through her deep experience, she leads the organization toward achieving its vision of building a more sustainable global food system in the face of climate change. Prior to joining Inari, she held several leadership roles including president of North America Seeds with Syngenta after earning her MBA from Cornell University and working with McKinsey & Company.

Pierre-Etienne Boin
CHIEF LEGAL OFFICER
READ BIO
About Pierre-Etienne Boin
Pierre-Etienne brings three decades of experience as an attorney specializing in international agribusiness and biotechnology law. He oversees all of Inari’s legal functions, leading a team working at the intersection of IP, compliance and regulatory strategy. Before joining Inari, Pierre-Etienne served as General Counsel for Seeds and Biotechnology globally at Syngenta and held various positions at Novartis Seeds. He received his law degree from the University of Fribourg, Switzerland, holds a Master's in European Law from Université Libre of Brussels, Belgium, and graduated from the Advanced Executive Program at Northwestern University's Kellogg School of Management.

Dr. Catherine Feuillet
CHIEF SCIENTIFIC OFFICER
READ BIO
About Dr. Catherine Feuillet
Using her deep experience in managing scientific innovation and extensive knowledge in genomics, Catherine leads the development of Inari's cutting-edge SEEDesign™ technology platform to unlock the full potential seed and help transform the global food system. Prior to Inari, she worked at Bayer CropScience as head of trait research and at the French National Institute for Agricultural Research (INRA) as research director leading the development of wheat genomics projects. Catherine is a co-founder of the International Wheat Genome Sequencing Consortium. She received her Ph.D. from Paul Sabatier University (France) and spent 10 years of academic research in Switzerland, where she researched disease-resistance genes and sought a better understanding of the evolution of wheat and barley.

Claudia Nari
CHIEF PRODUCT OFFICER
READ BIO
About Claudia Nari
Across more than three decades in the agriculture industry, Claudia has paired deep experience in plant breeding with a proven record of leading diverse, international teams. At Inari, she uses this expertise to help build a breakthrough product strategy that unlocks a more sustainable global food system and meets the needs of farmers everywhere. Previously, Claudia was Head of Regulatory Science Strategy and Operations at Bayer Crop Science after holding various roles at Monsanto across breeding and regulatory. She began her career in soybean improvement at Nidera Sementes (now part of Syngenta) after earning a plant breeding degree from Universidad de Buenos Aires in Argentina.

Ron Wulfkuhle
CHIEF COMMERCIAL OFFICER
READ BIO
About Ron Wulfkuhle
A 35-year agribusiness veteran, Ron is helping Inari build a novel commercial strategy that supports the planet, the population and the people who grow our food. Prior to joining Inari, he started and led F2F Genetics for Farmers Business Network, started and served as CEO of GreenLeaf Genetics, and held a number of leadership and global strategy roles for Syngenta and Novartis. Ron is a former member of the executive committee for the board of directors for the American Seed Trade Association and holds a degree in agronomy from Kansas State University.

Mark Berry
CHIEF PEOPLE OFFICER
READ BIO
About Mark Berry
Mark brings deep expertise in human resources and is a recognized leader in the field of workforce analytics. With a focus on data and insights, he helps define, shape and effectively scale Inari’s thriving culture within a fast-growing organization. Prior to joining Inari, Mark held senior HR leadership roles at Indiana Packers Corporation, CGB Enterprises, ConAgra Foods, and International Paper. Mark began his career as a licensed clinical counselor and served as director for several community-based social service agencies. He holds a MBA from Indiana State University and MA in psychology from Eastern Illinois University, with post-graduate work in psychological assessment and intervention.

Dr. Vivien Bonazzi
CHIEF DATA OFFICER
READ BIO
Dr. Vivien Bonazzi
Vivien draws on her three decades of expertise in life-sciences data and genomics to drive innovation and optimize the SEEDesign™ technology platform. Before joining Inari, she held pivotal roles as a Managing Director at Deloitte, where she founded the Biomedical Data Science group, as well as at the National Institutes of Health, Invitrogen, and Celera Genomics, where her responsibilities included developing, executing, and overseeing key R&D bioinformatics and whole-genome analysis initiatives. Vivien earned her Ph.D. in Molecular Biology, Pharmacology, and Computational Biology from the University of Melbourne, Australia.

Dr. Michael Kock
SVP, INNOVATION CATALYST
READ BIO
About Dr. Michael Kock
Michael brings more than 20 years experience creating and implementing holistic intellectual property strategies to drive innovation. His championing of collaborative innovation is paramount in enabling Inari to overcome hurdles and expedite positive change for the global food system. Before joining Inari, Michael was head of intellectual property at Syngenta for more than 10 years and senior IP counsel with BASF for 10 years. He received his Ph.D. in molecular biology from Hamburg University (Germany) and a J.D. in law from Humboldt University in Berlin (Germany), and is a qualified European and Swiss patent attorney.

Lara Smith Weber
CHIEF FINANCIAL OFFICER
READ BIO
About Lara Smith Weber
Lara brings more than 20 years of leadership experience in finance and strategy for publicly traded companies in the U.S. and Europe. Her demonstrated history working in biotechnology helps Inari build innovative corporate solutions and equips the organization with the resources to achieve our goal of building a more sustainable global food system. Lara joined Inari from ONWARD Medical, where she served as Chief Financial Officer. She previously held a variety of financial leadership roles, including at MorphoSys AG including US CFO and Senior VP Controlling and Corporate Finance, where she led its Nasdaq IPO. A graduate of Stanford University, she holds a bachelor’s degree in German studies, as well as both bachelor’s and master’s degrees in electrical engineering. She also holds an MBA from IMD in Switzerland.
Our Scientific Strategy Board
Comprising some of the brightest minds in modern science, their passion for our work helps unlock the full potential of our people. Through regular engagement with each of our teams, they help to set our direction - always challenging us to think bigger and bolder at every turn

Dr. George Church
SCIENTIFIC CO-FOUNDER AND SSB MEMBER
READ BIO
About Dr. George Church
As a professor of Genetics at Harvard Medical School, George collaborates with Inari to radically change crop improvement through the application of modern genome science. His Harvard PhD research developed the first methods for direct genome sequencing, molecular multiplexing, and barcoding, which led to the first genome sequence, in 1994. George's innovations have contributed to nearly all next generation DNA sequencing methods, and his lab's work on chip DNA synthesis, gene editing, and stem cell engineering have formed the foundation for many innovative companies. He has been elected to the National Academy of Sciences and the National Academy of Engineering.

Dr. Rodolphe Barrangou
CRISPR SYSTEM
READ BIO
About Dr. Rodolphe Barrangou
Rodolphe helps Inari optimize CRISPR-Cas systems in crops. He is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, where he focuses on the evolution and functions of CRISPR-Cas systems and their applications in bacteria. Rodolphe has received the Warren Alpert Foundation Prize, the Canada Gairdner International Award, the NAS Award in Molecular Biology, and the NAS Prize in Food and Agriculture Sciences. He is a member of the National Academy of Sciences.

Dr. Richard Flavell
PLANT MOLECULAR BIOLOGY
READ BIO
About Dr. Richard Flavell
Richard served as Interim chief scientific officer (CSO) at Inari, helping the company become strategically positioned in plant science and plant breeding. His career has been associated with plant genomics, plant breeding, the development and deployment of plant transformation, and the enhancement of agricultural traits in key crops. He has also served as Director of the John Innes Centre and as CSO of Ceres, Inc. He currently serves as chair of the International Wheat Yield Partnership. His scientific accomplishments have earned him the position of Fellow of the Royal Society.

Dr. Zach Lippman
FLOWER PRODUCTION
READ BIO
About Dr. Zach Lippman
Zach brings expertise in the application of modern genome editing technology as it relates to crop improvement. He is a professor at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute investigator. A pioneer in the application of CRISPR technology to alter plant gene activity and create novel allelic variation, Zach's research focuses on the process of flowering and flower production. He is a member of the National Academy of Sciences.

Dr. Steve Jacobsen
SCIENTIFIC CO-FOUNDER AND SSB MEMBER
READ BIO
About Dr. Steve Jacobsen
Steve advises Inari on establishing commercial applications for technologies that regulate gene expression and modulate the epigenome to improve crop performance. He is a professor in the Department of Molecular, Cell, and Developmental Biology at the University of California at Los Angeles and serves as an investigator for the Howard Hughes Medical Institute. His lab has been instrumental in defining the mechanism of action for several gene silencing pathways in plants. Steve earned his PhD at the University of Minnesota and completed his postdoctoral studies at the California Institute of Technology. He has been elected to the National Academy of Sciences and the American Academy of Sciences.

Dr. Jennifer Doudna
2020 NOBEL PRIZE WINNER
READ BIO
About Dr. Jennifer Doudna
Jennifer helps Inari optimize CRISPR technology for crop improvement. She shares the 2020 Nobel Prize for Chemistry for her work to identify and develop CRISPR-Cas9. Jennifer is the Li Ka Shing Chancellor's Professor in Biomedical and Health at University of California, Berkeley, and a Howard Hughes Medical Institute (HHMI) investigator. Jennifer's lab studies many aspects of RNA biology and discovered the programmable nature of Cas nucleases. She received a Packard Foundation Fellow Award and the American Association for the Advancement of Science Fellow Award and has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, Institute of Medicine of the National Academies, and the Royal Society.

Dr. Dirk Inze
PLANT MOLECULAR GENETICS
READ BIO
About Dr. Dirk Inze
Dirk brings expertise in the development of novel solutions to major crop production challenges. He is a principal investigator and science director at VIB, a life sciences research institute in Belgium. His research aims to understand plant growth. His lab takes a systems biology approach to explore the mechanisms of leaf growth in Arabidopsis and maize, discoveries applied to improve crop productivity and response to the environment. He has been awarded the World Agriculture Prize and the Körber Stiftung Prize.

Dr. Jonathan Pritchard
COMPUTATIONAL GENOMICS
READ BIO
About Dr. Jonathan Pritchard
Jonathan brings expertise in statistical and computational methods to the study of genomics and evolutionary biology. He developed STRUCTURE, a widely used computer program for determining population structure. He is a professor in the departments of genetics and biology at Stanford University. Jonathan holds Biology and Mathematics degrees from Penn State, a PhD in Biology from Stanford, and he completed post-doctoral work in Statistics at Oxford University. He was awarded the Edward Novitski Prize for creativity and intellectual ingenuity in solving significant problems in genetics research and the Mitchell Prize from the International Society for Bayesian Analysis.
Our Board
You can achieve great things when your board is passionate about the vision and mission of the organization. Our board brings experience and depth of knowledge to further enhance the talents of the team.

Ignacio Martinez
CO-FOUNDER AND CHAIR
READ BIO
About Ignacio Martinez
Ignacio was founding CEO of Inari as well as a general partner of Flagship Pioneering. Ignacio joined Flagship to lead its sustainability activities in addition to entrepreneurial activities in life sciences, with a special interest on food, nutrition, and health. Ignacio is co-founder and founding CEO of CiBO Technologies, Inari Agriculture, Invaio Sciences, Senda Biosciences, Montai Health and founding director at Indigo Agriculture. Prior to joining Flagship, Ignacio was a managing director of Syngenta Ventures. He holds an International MBA from Instituto de Empresain Spain and WHU Otto Beisheim School of Management in Germany.

Dr. Robert Berendes
DIRECTOR
READ BIO
About Dr. Robert Berendes
Robert is an executive partner at Flagship Pioneering and chairman of Indigo Ag, Invaio Sciences, and CiBO Technologies. Previously, he served as Syngenta's global head of business development and member of its executive committee. Prior to that, he was a partner at McKinsey & Co. Robert has a PhD in Biophysics from the Max Planck Institute for Biochemistry and Technical University of Munich, and a diploma in Chemistry from the University of Cologne.

Howard W. Buffett
DIRECTOR
READ BIO
About Howard W. Buffett
Howard is a professor at Columbia University with research focused on social and sustainability-related impact measurement and analysis. Previously, he was executive director of the Howard G. Buffett Foundation, which strengthens food security for vulnerable populations throughout the world. He also oversaw agricultural economic redevelopment and stability programs in Afghanistan and Iraq for the U.S. Department of Defense, and was a policy advisor for the White House Domestic Policy Council. He is on boards for Case New Holland Industrial (NYSE:CNHI), Toyota (NYSE:TM), REEF Technology, and S2G Ventures.

Dr. Joon Jin
DIRECTOR
READ BIO
About Joon Jin
Joon Jin is Senior Vice President of Bio Strategy at Hanwha Impact, where he leads corporate strategy, business development, and equity investments for its emerging biotechnology business. Hanwha Impact's investment in Inari supports Hanwha's group-wide sustainability ambitions. Joon was previously acting president of CJ Biomaterials (formerly Metabolix) of CJ Group, overseeing all business activities and the company's research and development efforts in biobased polymers, synthetic biology, microbiome, and exosome-based therapeutics. He holds a Ph.D. in cell and molecular biology from POSTECH, an M.B.A. from Boston University, and a B.S. in plant science from Seoul National University.

Dr. Sophie V. Vandebroek
DIRECTOR
READ BIO
About Dr. Sophie V. Vandebroek
Sophie is a seasoned C-level technology executive and a fellow of the Institute Electrical & Electronics Engineers holding 14 US patents. She is the founder of Strategic Vision Ventures, a strategic advisory firm, where she shares her expertise developing innovative concepts from fundamental research to commercial offerings. Sophie previously was the chief operating officer of IBM research, and was with Xerox for over 25 years, including a decade as their chief technology officer. Sophie serves as an independent non-executive director on the IDEXX Laboratories and the Wolters Kluwer N.V. boards and is a trustee at the Boston Museum of Science. She graduated with her masters in engineering from KU Leuven in Belgium, and earned her Ph.D. from Cornell University.

Bob Bechek
DIRECTOR
READ BIO
About Bob Bechek
Bob is a partner and former worldwide managing director (CEO) and board chair of consulting firm Bain & Company, where he's held a number of leadership and governance roles across his 32 years with the organization. Prior to joining Bain, Bob led mechanical research and development for AKR Robotics in Paris, France. He later founded the U.S. subsidiary, as vice president and general manager. Bob received his MBA from Harvard University and a bachelor's degree in Mechanical Engineering from the Massachusetts Institute of Technology.

Stephen Berenson
DIRECTOR
READ BIO
About Stephen Berenson
Stephen is a Managing Partner at Flagship Pioneering and a member of the company's Resource Allocation and Management Committees. He is also responsible for its Capital Formation and Business Development functions. While serving as chairman for Cellarity and Seres Therapeutics, he is also on the board of directors of Moderna. Stephen previously spent more than three decades as an investment banker at J.P. Morgan – working across all major geographies, product areas and industry groups, and helping build the bank’s M&A, equities and technology investment banking businesses. He holds an S.B. in mathematics from MIT.

Solange Bullukian
DIRECTOR
READ BIO
About Solange Bullukian
Solange is a veteran executive finance and accounting leader with extensive Fortune 500 and startup experience, including in the life sciences, technology, and computing industries. She is the founder and managing director of Scale2Growth, which specializes in supporting companies through periods of rapid expansion. Solange began her career as a financial analyst at Hewlett-Packard before rising to leadership roles at HP spinoff Agilent Technologies, including Chief Financial Officer of the company's Life Sciences Group and Chief Accounting Officer. She later joined synthetic DNA startup Twist Bioscience, where she oversaw a successful Series D fundraising and prepared the company for IPO. Solange holds a master's degree in management and majored in entrepreneurship from the HEC Paris School of Management. She is also a board member and audit committee chair at Olink (NASDAQ: OLK) and Lumicks.

Ponsi Trivisvavet
CEO AND DIRECTOR
READ BIO
About Ponsi Trivisvavet
Ponsi's broad management expertise in global agriculture has helped her build Inari into the cutting-edge SEEDesign™ technology company. Through her deep experience, she leads the organization toward achieving its vision of building a more sustainable global food system in the face of climate change. Prior to joining Inari, she held several leadership roles including president of North America Seeds with Syngenta after earning her MBA from Cornell University and working with McKinsey & Company.

Join Us
We are driven by our mission to build a more sustainable global food system for the benefit of farmers, society and the planet. If you want to challenge the status quo within our bold, diverse culture, join us - and find out how you can help grow tomorrow with Inari.